170 related articles for article (PubMed ID: 21354958)
1. [Complete and sustained remission of liver metastases from neuroendocrine tumor with somatostatin analogue therapy].
Raizer G; Igaz P; Pregun I; Dabasi G; Rácz K
Orv Hetil; 2011 Mar; 152(10):407-10. PubMed ID: 21354958
[TBL] [Abstract][Full Text] [Related]
2. A non-functioning pancreatic neuroendocrine tumour: a case report.
Rosiek V; Kunikowska J; Kos-Kudła B
Endokrynol Pol; 2012; 63(1):59-64. PubMed ID: 22378100
[TBL] [Abstract][Full Text] [Related]
3. Rectal neuroendocrine tumor presenting as a polyp with hepatic metastases.
Meriam S; Trad D; Jouini R; Haddad D; Ouakaa A
Gastrointest Endosc; 2019 Oct; 90(4):688-689. PubMed ID: 31375265
[No Abstract] [Full Text] [Related]
4. Tumor imaging and therapy using radiolabeled somatostatin analogues.
de Jong M; Breeman WA; Kwekkeboom DJ; Valkema R; Krenning EP
Acc Chem Res; 2009 Jul; 42(7):873-80. PubMed ID: 19445476
[TBL] [Abstract][Full Text] [Related]
5. Multiple effects of somatostatin analogs verified in three cases of metastasized neuroendocrine tumors of the gastroenteropancreatic system.
Biliotti G; Martini F; Vaggelli L; Messerini L; Colagrande S; Pupi A; Seghi P
Tumori; 2006; 92(2):170-4. PubMed ID: 16724698
[TBL] [Abstract][Full Text] [Related]
6. Hypoglycemia induced by long-acting somatostatin analogues in a patient with nonfunctional neuroendocrine tumor.
Unek IT; Celtik A; Yener S; Yavuzsen T; Alacacioglu A; Cokmert S; Oztop I; Demirkan B; Dicle O; Sagol O; Bekis R; Yilmaz U
J BUON; 2009; 14(1):135-8. PubMed ID: 19365885
[TBL] [Abstract][Full Text] [Related]
7. Induction of apoptosis in neuroendocrine tumors of the digestive system during treatment with somatostatin analogs.
Imam H; Eriksson B; Lukinius A; Janson ET; Lindgren PG; Wilander E; Oberg K
Acta Oncol; 1997; 36(6):607-14. PubMed ID: 9408151
[TBL] [Abstract][Full Text] [Related]
8. Complete clinical remission and disappearance of liver metastases after treatment with somatostatin analogue in a 40-year-old woman with a malignant insulinoma positive for somatostatin receptors type 2.
Romeo S; Milione M; Gatti A; Fallarino M; Corleto V; Morano S; Baroni MG
Horm Res; 2006; 65(3):120-5. PubMed ID: 16479142
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of octreotide in the regression of a metastatic carcinoid tumour despite negative imaging with In-111-pentetreotide (Octreoscan).
Hillman N; Herranz L; Alvarez C; Martínez Olmos MA; Márco A; Gómez-Pan A
Exp Clin Endocrinol Diabetes; 1998; 106(3):226-30. PubMed ID: 9710364
[TBL] [Abstract][Full Text] [Related]
10. [Efficacy of somatostatin analogues in the treatment of neuroendocrine tumours based on the results of recent clinical trials].
Igaz P
Orv Hetil; 2014 Nov; 155(48):1908-12. PubMed ID: 25417137
[TBL] [Abstract][Full Text] [Related]
11. The management of gastroenteropancreatic neuroendocrine tumors with somatostatin analogues.
Khagi S; Saif MW
JOP; 2014 Jul; 15(4):295-8. PubMed ID: 25076324
[TBL] [Abstract][Full Text] [Related]
12. [Role of somatostatin analogs in the treatment of neuroendocrine tumours].
Cuccurullo V; Cascini GL; Rambaldi PF; Mansi L
Minerva Endocrinol; 2001 Sep; 26(3):135-43. PubMed ID: 11753236
[TBL] [Abstract][Full Text] [Related]
13. Peptide Receptor Radionuclide Therapy with radiolabelled somatostatin analogues in patients with somatostatin receptor positive tumours.
Van Essen M; Krenning EP; De Jong M; Valkema R; Kwekkeboom DJ
Acta Oncol; 2007; 46(6):723-34. PubMed ID: 17653893
[TBL] [Abstract][Full Text] [Related]
14. Diffuse Bone Metastases in Pancreatic Neuroendocrine Tumor Shown on Octreoscan.
Adkins J; Lu Y
Clin Nucl Med; 2019 Mar; 44(3):257-258. PubMed ID: 30624276
[TBL] [Abstract][Full Text] [Related]
15. [Efficacy of somatostatin analogs in the treatment of neuroendocrine tumours and paraneoplastic syndromes].
Sperlongano P; De Falco M; Pisaniello D; Parmeggiani D; Parmeggiani U
Minerva Endocrinol; 2001 Dec; 26(4):293-5. PubMed ID: 11782719
[TBL] [Abstract][Full Text] [Related]
16. Somatostatin analogues in the treatment of gastroenteropancreatic neuroendocrine tumors.
Delaunoit T; Rubin J; Neczyporenko F; Erlichman C; Hobday TJ
Mayo Clin Proc; 2005 Apr; 80(4):502-6. PubMed ID: 15819288
[TBL] [Abstract][Full Text] [Related]
17. Somatostatin receptor scintigraphy in liver metastasis detection from gastroenteropancreatic neuroendocrine tumors.
Schillaci O; Spanu A; Scopinaro F; Falchi A; Danieli R; Marongiu P; Pisu N; Madeddu G; Delle Fave G; Madeddu G
J Nucl Med; 2003 Mar; 44(3):359-68. PubMed ID: 12621001
[TBL] [Abstract][Full Text] [Related]
18. [Neuroendocrine lung tumor with liver metastases and carcinoid syndrome].
Argibay Vázquez S; Núñez Cambre I; Luna Vega V; Ruibal Morell A
Med Clin (Barc); 2007 Mar; 128(11):440. PubMed ID: 17394864
[No Abstract] [Full Text] [Related]
19. Somatostatin-receptor-based imaging and therapy of gastroenteropancreatic neuroendocrine tumors.
Kwekkeboom DJ; Kam BL; van Essen M; Teunissen JJ; van Eijck CH; Valkema R; de Jong M; de Herder WW; Krenning EP
Endocr Relat Cancer; 2010 Mar; 17(1):R53-73. PubMed ID: 19995807
[TBL] [Abstract][Full Text] [Related]
20. [Efficacy of prolonged-release somatostatin analog monotherapy in metastatic endocrine tumors].
Kanyinda-K JM; Samalin E; Sebah H; Gallix B; Ychou M
Gastroenterol Clin Biol; 2008 Dec; 32(12):989-91. PubMed ID: 18945567
[No Abstract] [Full Text] [Related]
[Next] [New Search]
